How to buy Encompass Health Corporation stock | $84.44

Encompass Health Corporation is a medical care facilities business based in the US. Encompass Health Corporation shares (EHC) are listed on the NYSE and all prices are listed in US Dollars. Encompass Health Corporation employs 27,970 staff and has a trailing 12-month revenue of around USD$4.6 billion.

How to buy shares in Encompass Health Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Encompass Health Corporation. Find the stock by name or ticker symbol: EHC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Encompass Health Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$84.44, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Encompass Health Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Encompass Health Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Encompass Health Corporation share price

Use our graph to track the performance of EHC stocks over time.

Encompass Health Corporation shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$84.44
52-week range	USD$47.363 - USD$87.11
50-day moving average	USD$79.2479
200-day moving average	USD$68.3359
Wall St. target price	USD$89.79
PE ratio	30.9663
Dividend yield	USD$1.12 (1.35%)
Earnings per share (TTM)	USD$2.67

Buy Encompass Health Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Encompass Health Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Encompass Health Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Encompass Health Corporation price performance over time

Historical closes compared with the close of $84.44 from 2020-12-11

1 week (2021-01-07)	-1.81%
1 month (2020-12-17)	1.64%
3 months (2020-10-15)	23.98%
6 months (2020-07-15)	29.49%

1 year (2020-01-15)	8.95%
2 years (2019-01-15)	28.04%
3 years (2018-01-13)	N/A
5 years (2016-01-15)	149.53%

Is Encompass Health Corporation under- or over-valued?

Valuing Encompass Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Encompass Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Encompass Health Corporation's P/E ratio

Encompass Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Encompass Health Corporation shares trade at around 31x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Encompass Health Corporation's EBITDA

Encompass Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$856.5 million.

The EBITDA is a measure of a Encompass Health Corporation's overall financial performance and is widely used to measure a its profitability.

Encompass Health Corporation financials

Revenue TTM	USD$4.6 billion
Operating margin TTM	13.38%
Gross profit TTM	USD$1.9 billion
Return on assets TTM	5.94%
Return on equity TTM	18.23%
Profit margin	5.76%
Book value	$15.3
Market capitalisation	USD$8.2 billion

TTM: trailing 12 months

Shorting Encompass Health Corporation shares

There are currently 2.1 million Encompass Health Corporation shares held short by investors – that's known as Encompass Health Corporation's "short interest". This figure is 6.5% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Encompass Health Corporation shares can be evaluated.

Encompass Health Corporation's "short interest ratio" (SIR)

Encompass Health Corporation's "short interest ratio" (SIR) is the quantity of Encompass Health Corporation shares currently shorted divided by the average quantity of Encompass Health Corporation shares traded daily (recently around 648214.84848485). Encompass Health Corporation's SIR currently stands at 3.3. In other words for every 100,000 Encompass Health Corporation shares traded daily on the market, roughly 3300 shares are currently held short.

However Encompass Health Corporation's short interest can also be evaluated against the total number of Encompass Health Corporation shares, or, against the total number of tradable Encompass Health Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Encompass Health Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Encompass Health Corporation shares in existence, roughly 20 shares are currently held short) or 0.0275% of the tradable shares (for every 100,000 tradable Encompass Health Corporation shares, roughly 28 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Encompass Health Corporation.

Find out more about how you can short Encompass Health Corporation stock.

Encompass Health Corporation share dividends

Dividend payout ratio: 39.86% of net profits

Recently Encompass Health Corporation has paid out, on average, around 39.86% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.35% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Encompass Health Corporation shareholders could enjoy a 1.35% return on their shares, in the form of dividend payments. In Encompass Health Corporation's case, that would currently equate to about $1.12 per share.

While Encompass Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Encompass Health Corporation may be investing much of the rest of its net profits in future growth.

Encompass Health Corporation's most recent dividend payout was on 15 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 31 December 2020 (the "ex-dividend date").

Have Encompass Health Corporation's shares ever split?

Encompass Health Corporation's shares were split on a 1:5 basis on 26 October 2006. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Encompass Health Corporation shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Encompass Health Corporation shares which in turn could have impacted Encompass Health Corporation's share price.

Encompass Health Corporation share price volatility

Over the last 12 months, Encompass Health Corporation's shares have ranged in value from as little as $47.363 up to $87.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Encompass Health Corporation's is 1.1113. This would suggest that Encompass Health Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Encompass Health Corporation overview

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of November 16, 2020, Encompass Health Corporation operated 137 hospitals, 242 home health locations, and 83 hospice locations in 39 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Frequently asked questions

• What percentage of Encompass Health Corporation is owned by insiders or institutions?

  Currently 1.462% of Encompass Health Corporation shares are held by insiders and 95.309% by institutions.

• How many people work for Encompass Health Corporation?

  Latest data suggests 27,970 work at Encompass Health Corporation.

• When does the fiscal year end for Encompass Health Corporation?

  Encompass Health Corporation's fiscal year ends in December.

• Where is Encompass Health Corporation based?

  Encompass Health Corporation's address is: 9001 Liberty Parkway, Birmingham, AL, United States, 35242

• What is Encompass Health Corporation's ISIN number?

  Encompass Health Corporation's international securities identification number is: US29261A1007

• What is Encompass Health Corporation's CUSIP number?

  Encompass Health Corporation's Committee on Uniform Securities Identification Procedures number is: 29261A100